C-MER Medical (03309) Announces Share Repurchase and Revised Issued Shares

Bulletin Express11-26

C-MER Medical Holdings Limited (Stock Code: 03309) announced that on 26 November 2025, 160,000 ordinary shares were repurchased on the market at prices ranging from HKD 1.72 to HKD 1.74 each, totaling HKD 277,200. Following this transaction, the issuer holds 17,448,000 treasury shares, while its number of issued shares (excluding treasury shares) stands at 1,238,112,870.

The issuer also disclosed that a series of share repurchases for cancellation remain outstanding, dating from July 2024 through May 2025. These repurchased shares have not yet been cancelled but continue to be accounted for in the overall share capital figures.

Under the latest repurchase mandate passed on 19 May 2025, the issuer is authorized to repurchase up to 125,556,087 shares. The newly completed transaction on 26 November 2025 represents approximately 0.0129% of the issued shares on the date of the resolution granting this mandate. A moratorium on any new issue of shares or sale or transfer of treasury shares runs until 26 December 2025, in line with applicable listing rules and regulations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1155947457?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-26 19:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1155947457","market":"us","top_or_hot":-1,"title":"C-MER Medical (03309) Announces Share Repurchase and Revised Issued Shares","media":"Bulletin Express","content":"<p>C-MER Medical Holdings Limited (Stock Code: 03309) announced that on 26 November 2025, 160,000 ordinary shares were repurchased on the market at prices ranging from HKD 1.72 to HKD 1.74 each, totaling HKD 277,200. Following this transaction, the issuer holds 17,448,000 treasury shares, while its number of issued shares (excluding treasury shares) stands at 1,238,112,870.</p>\n<p>The issuer also disclosed that a series of share repurchases for cancellation remain outstanding, dating from July 2024 through May 2025. These repurchased shares have not yet been cancelled but continue to be accounted for in the overall share capital figures.</p>\n<p>Under the latest repurchase mandate passed on 19 May 2025, the issuer is authorized to repurchase up to 125,556,087 shares. The newly completed transaction on 26 November 2025 represents approximately 0.0129% of the issued shares on the date of the resolution granting this mandate. A moratorium on any new issue of shares or sale or transfer of treasury shares runs until 26 December 2025, in line with applicable listing rules and regulations.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>C-MER Medical (03309) Announces Share Repurchase and Revised Issued Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nC-MER Medical (03309) Announces Share Repurchase and Revised Issued Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-26 19:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>C-MER Medical Holdings Limited (Stock Code: 03309) announced that on 26 November 2025, 160,000 ordinary shares were repurchased on the market at prices ranging from HKD 1.72 to HKD 1.74 each, totaling HKD 277,200. Following this transaction, the issuer holds 17,448,000 treasury shares, while its number of issued shares (excluding treasury shares) stands at 1,238,112,870.</p>\n<p>The issuer also disclosed that a series of share repurchases for cancellation remain outstanding, dating from July 2024 through May 2025. These repurchased shares have not yet been cancelled but continue to be accounted for in the overall share capital figures.</p>\n<p>Under the latest repurchase mandate passed on 19 May 2025, the issuer is authorized to repurchase up to 125,556,087 shares. The newly completed transaction on 26 November 2025 represents approximately 0.0129% of the issued shares on the date of the resolution granting this mandate. A moratorium on any new issue of shares or sale or transfer of treasury shares runs until 26 December 2025, in line with applicable listing rules and regulations.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03309","symbol_name":"希玛医疗","start_time":0,"source_url":"","article_id":"1155947457","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1155947457","pubTimestamp":1764157372,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"C-MER Medical Holdings Limited (Stock Code: 03309) announced that on 26 November 2025, 160,000 ordinary shares were repurchased on the market at prices ranging from HKD 1.72 to HKD 1.74 each,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03309":"希玛医疗"},"translate_title":"C-MER医疗(03309)公布购回股份及修订已发行股份","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03309":1},"content_text":"C-MER Medical Holdings Limited (Stock Code: 03309) announced that on 26 November 2025, 160,000 ordinary shares were repurchased on the market at prices ranging from HKD 1.72 to HKD 1.74 each, totaling HKD 277,200. Following this transaction, the issuer holds 17,448,000 treasury shares, while its number of issued shares (excluding treasury shares) stands at 1,238,112,870.\nThe issuer also disclosed that a series of share repurchases for cancellation remain outstanding, dating from July 2024 through May 2025. These repurchased shares have not yet been cancelled but continue to be accounted for in the overall share capital figures.\nUnder the latest repurchase mandate passed on 19 May 2025, the issuer is authorized to repurchase up to 125,556,087 shares. The newly completed transaction on 26 November 2025 represents approximately 0.0129% of the issued shares on the date of the resolution granting this mandate. A moratorium on any new issue of shares or sale or transfer of treasury shares runs until 26 December 2025, in line with applicable listing rules and regulations.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1155947457","isCrawlerRequest":true}